Genetic association between G protein-coupled receptor kinase 6/β-arrestin 2 and dopamine supersensitivity psychosis in schizophrenia

Neuropsychiatric Disease and Treatment

Volumn 11, Issue , 2015, Pages 1845-1851

  Oda, Yasunori ^a   Kanahara, Nobuhisa ^b   Kimura, Hiroshi ^a   Watanabe, Hiroyuki ^b   Hashimoto, Kenji ^b   Iyo, Masaomi ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b CHIBA UNIVERSITY   (Japan)

Author keywords

Antipsychotic; Dopamine D2 receptor; Tardive dyskinesia; Treatment resistant

Indexed keywords

BETA ARRESTIN 2; DOPAMINE 2 RECEPTOR; G PROTEIN COUPLED RECEPTOR KINASE 6; NEUROLEPTIC AGENT;

ADULT; AGED; ARRB2 GENE; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE CLASSIFICATION; DOPAMINE SUPERSENSITIVITY PSYCHOSIS; DRUG TOLERANCE; FEMALE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC PARAMETERS; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; GRK6 GENE; HARDY WEINBERG EQUILIBRIUM; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT CODING; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN TRANSPORT; PSYCHOSIS; RETROSPECTIVE STUDY; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION;

EID: 84938256003     PISSN: None     EISSN: 11782021     Source Type: Journal    
DOI: 10.2147/NDT.S86042     Document Type: Article

References (27)

1. Seeman P. Targeting the dopamine D2 receptor in schizophrenia. Expert Opin Ther Targets. 2006;10:515-531.
2. Kane J, Honigfeld G, Singer J, et al. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry. 1988;45:789-796.
3. Brenner HD, Dencker SJ, Goldstein MJ, et al. Defining treatment refractoriness in schizophrenia. Schizophr Bull. 1990;16:551-561.
4. Moncrieff J. Does antipsychotic withdrawal provoke psychosis? Review of the literature on rapid onset psychosis (supersensitivity psychosis) and withdrawal-related relapse. Acta Psychiatr Scand. 2006;114:3-13.
5. Iyo M, Tadokoro S, Kanahara N, et al. Optimal extent of dopamine D2 receptor occupancy by antipsychotics for treatment of dopamine supersensitivity psychosis and late-onset psychosis. J Clin Psychopharmacol. 2013;33:398-404.
6. Chouinard G, Chouinard VA. A typical antipsychotics: CATIE study, drug-induced movement disorder and resulting iatrogenic psychiatric-like symptoms, supersensitivity rebound psychosis and withdrawal discontinuation syndromes. Psychother Psychosom. 2008;77:69-77.
7. Köhler U, Schröder H, Augusatin W, Sabel BA. A new animal model of dopamine supersensitivity using s.c. implantation of haloperidol releasing polymers. Neurosci Lett. 1994;170:99-102.
8. Huang N, Ase AR, Hébert C, van Gelder NM, Reader TA. Effects of chronic neuroleptic treatments on dopamine D1 and D2 receptors: homogenate binding and autoradiographic studies. Neurochem Int. 1997;30:277-290.
9. Inoue A, Miki S, Seto M, et al. Aripiprazole, a novel antipsychotic drug, inhibits quinpirole-evoked GTPase activity but does not up-regulate dopamine D2 receptor following repeated treatment in the rat striatum. Eur J Pharmacol. 1997;321:105-111.
10. Silvestri S, Seeman MV, Negrete JC, et al. Increased dopamine D2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study. Psychopharmacology (Berl). 2000;152:174-180.
11. Tadokoro S, Okamura N, Sekine Y, Kanahara N, Hashimoto K, Iyo M. Chronic treatment with aripiprazole prevents development of dopamine supersensitivity and potentially supersensitivity psychosis. Schizophr Bull. 2011;38:1012-1020.
12. Suzuki T, Kanahara N, Yamanaka H, et al. Dopamine supersensitivity psychosis as a pivotal factor in treatment-resistant schizophrenia. Psychiatr Res. 2015;227:278-282.
13. Métayé T, Gibelin H, Perdrisot R, Kraimps JL. Pathophysiological roles of G-protein-coupled receptor kinases. Cell Signal. 2005;17:917-928.
14. Ikeda M, Ozaki N, Suzuki T, et al. Possible association of beta-arrestin 2 gene with methamphetamine use disorder, but not schizophrenia. Genes Brain Behav. 2007;6:107-112.
15. Liou YJ, Wang YC, Chen JY, et al. The coding-synonymous polymorphism rs1045280 (Ser280Ser) in beta-arrestin 2 (ARRB2) gene is associated with tardive dyskinesia in Chinese patients with schizophrenia. Eur J Neurol. 2008;15:1406-1408.
16. Tang W, Cai J, Yi Z, Zhang Y, Lu W, Zhang C. Association study of common variants within the G protein-coupled receptor kinase 6 gene and schizophrenia susceptibility in Han Chinese. Hum Psychopharmacol. 2014;29:100-103.
17. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th-TR ed. Washington, DC: American Psychiatric Press; 2000.
18. Chouinard G. Severe cases of neuroleptic-induced supersensitivity psychosis. Diagnostic criteria for the disorder and its treatment. Schizophr Res. 1990;5:21-33.
19. Kirkpatrick B, Alphs L, Buchanan RW. The concept of supersensitivity psychosis. J Nerv Ment Dis. 1992;180:265-270.
20. Hirakawa M, Tanaka T, Hashimoto Y, et al. JSNP: a database of common gene variation in the Japanese population. Nucleic Acids Res. 2002;30:158-162.
21. Erdtmann-Vourliotis M, Mayer P, Ammon S, Riechert U, Höllt V. Distribution of G-protein-coupled receptor kinase (GRK) isoforms 2, 3, 5 and 6 mRNA in the rat brain. Brain Res Mol Brain Res. 2001;95:129-137.
22. Ahmed MR, Berthet A, Bychkov E, et al. Lentiviral overexpression of GRK6 alleviates L-dopa-induced dyskinesia in experimental Parkinson's disease. Sci Transl Med. 2010;2:28ra28.
23. Gainetdinov RR, Bohn LM, Sotnikova TD, et al. Dopaminergic supersensitivity in G protein-coupled receptor kinase 6-deficient mice. Neuron. 2003;38:291-303.
24. Managò F, Espinoza S, Salahpour A, et al. The role of GRK6 in animal models of Parkinson's disease and L-DOPA treatment. Sci Rep. 2012;2:301.
25. Bohn LM, Gainetdinov RR, Caron MG. G protein-coupled receptor kinase/beta-arrestin systems and drugs of abuse: psychostimulant and opiate studies in knockout mice. Neuromolecular Med. 2004;5:41-50.
26. Chouinard G, Annable L, Chouinard AR. Supersensitivity psychosis and tardive dyskinesia: a survey in schizophrenic outpatients. Psychopharmacol Bull. 1986;22:891-896.
27. Hunt JI, Singh H, Simpson GM. Neuroleptic-induced supersensitivity psychosis: retrospective study of schizophrenic inpatients. J Clin Psychiatry. 1988;49:258-261.